Anika Therapeutics Inc. | Income Statement

Fiscal year is January-December. All values USD Thousands.
2013
2014
2015
2016
2017
2018
Sales/Revenue
75,081.20
105,594.80
92,999.00
103,379.00
113,420.00
105,555
Cost of Goods Sold (COGS) incl. D&A
22,765.40
20,930.30
21,053.00
24,027.00
27,364.00
31,280
Gross Income
52,315.80
84,664.50
71,946.00
79,352.00
86,056.00
74,275
SG&A Expense
19,995.90
23,217.60
23,812.00
28,745.00
40,327.00
52,526
EBIT
32,319.90
61,446.90
48,134.00
50,607.00
45,729.00
21,749
Unusual Expense
286.80
-
-
-
-
-
Interest Expense
127.20
-
-
-
-
-
Pretax Income
32,479.50
61,505.00
48,254.00
50,870.00
46,202.00
23,207
Income Tax
11,905.00
23,185.50
17,496.00
18,323.00
14,386.00
4,485
Consolidated Net Income
20,574.50
38,319.50
30,758.00
32,547.00
31,816.00
18,722
Net Income
20,574.50
38,319.50
30,758.00
32,547.00
31,816.00
18,722
Net Income After Extraordinaries
20,574.50
38,319.50
30,758.00
32,547.00
31,816.00
18,722
Net Income Available to Common
20,574.50
38,319.50
30,758.00
32,547.00
31,816.00
18,722
EPS (Basic)
1.39
2.51
2.01
2.15
2.11
1.27
Basic Shares Outstanding
14,086.90
14,678.20
14,934.00
14,682.00
14,575.00
14,442
EPS (Diluted)
1.39
2.51
2.01
2.15
2.11
1.27
Diluted Shares Outstanding
14,825.60
15,269.40
15,321.00
15,116.00
15,068.00
14,689
EBITDA
37,092.40
66,152.50
51,909.00
54,341.00
50,019.00
27,659
Non-Operating Interest Income
-
58.10
120.00
263.00
473.00
1,458

About Anika Therapeutics

View Profile
Address
32 Wiggins Avenue
Bedford Massachusetts 01730
United States
Employees -
Website http://www.anikatherapeutics.com
Updated 07/08/2019
Anika Therapeutics, Inc. is global medical technology company, which develops, manufactures and commercializes therapeutic products for pain management, tissue regeneration, and wound healing. Its products are based on hyaluronic acid, a natural chemical occurring, biocompatible polymer found throughout the body. It offers therapeutic products which include orthobiologics, dermal, ophthalmic, surgical and veterinary.